An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
York (UK): Centre for Reviews and Dissemination (UK); 1995-.
Top results in this bookTable of Contents
A Systematic Review of Intravitreal Bevacizumab for the Treatment of Diabetic Macular Edema [Internet].
Fortin P, Mintzes B, Innes M.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2012 May.
Molecular Imaging and Contrast Agent Database (MICAD) [Internet].
Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
Comparative Clinical and Economic Effectiveness of Anti-vascular Endothelial Growth Factor Agents [Internet].
Low A, Kansagara D, Freeman M, et al.
Washington (DC): Department of Veterans Affairs (US); 2017 Jan.
StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2024 Jan-.
Faricimab (Vabysmo): CADTH Reimbursement Review: Therapeutic area: Macular degeneration, age-related [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Nov.
Ranibizumab (Lucentis): Visual Impairment due to Choroidal Neovascularization Secondary to Pathologic Myopia [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Aug.
Madame Curie Bioscience Database [Internet].
Austin (TX): Landes Bioscience; 2000-2013.
Brolucizumab (Beovu): CADTH Reimbursement Review: Therapeutic area: Diabetic macular edema [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Mar.
Faricimab (Vabysmo): CADTH Reimbursement Review: Therapeutic area: Diabetic macular edema [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Jan.
Endotext [Internet].
Feingold KR, Anawalt B, Blackman MR, et al., editors.
South Dartmouth (MA): MDText.com, Inc.; 2000-.
Aflibercept (Eylea): Treatment of Neovascular (Wet) Age-Related Macular Degeneration (wAMD) [Internet].
Clinical Review Report: Dexamethasone (Ozurdex): (Allergan Inc.): Indication: For the treatment of adult patients with diabetic macular edema who are pseudophakic [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Nov.
Dexamethasone Intravitreal Implant (Ozurdex): CADTH Reimbursement Review: Therapeutic area: Diabetic macular edema [Internet].
Sotorasib (Lumakras): Therapeutic area: KRAS G12C-mutated, advanced non–small cell lung cancer: CADTH Reimbursement Review [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Jul.
Faricimab (Vabysmo): CADTH Reimbursement Recommendation: Indication: For the treatment of neovascular (wet) age-related macular degeneration [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Aug.
Drugs and Lactation Database (LactMed®) [Internet].
Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
NTP Research Report on the Preliminary Evaluation of 4-Methylcyclohexylmethanol in an In Vitro Human Airway Model: Research Report 7 [Internet].
Gwinn WM, Bousquet RW, Perry CE, et al.
Durham (NC): National Toxicology Program; 2018 Dec.
Faricimab (Vabysmo): CADTH Reimbursement Recommendation: Indication: For the treatment of diabetic macular edema [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Oct.
Tremelimumab (Imjudo) in Combination With Durvalumab (Imfinzi): CADTH Reimbursement Review: Therapeutic area: Unresectable hepatocellular carcinoma [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Jan.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on